Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,666.12
(
-0.74%
)
US TECH 100
24,027.20
(
-0.44%
)
Dow Jones
46,507.28
(
-1.03%
)
Brent Oil
104.48
(
3.80%
)
Bitcoin
71,653.89
(
-3.09%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 128959

Friday, 10/21/2011 12:58:28 PM

Friday, October 21, 2011 12:58:28 PM

Post# of 257253

I just read Feuerstein’s piece saying that VRUS might owe royalties to IDIX on its nuke IP, and I think there’s no substance to it. But this has nothing to do with the looming competition from ABT in all-oral HCV cocktails, which is presumably the reason for VRUS’ selloff today.




What do you find so appealing about ABT's all-oral offering?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today